The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Clinical Outcomes Following Institution of the Canadian Universal Leukoreduction Program for Red Blood Cell Transfusions
Abstract
Context: A number of countries have implemented a policy of universal leukoreduction of their blood supply, but the potential role of leukoreduction in decreasing postoperative mortality and infection is unclear. Objective: To evaluate clinical outcomes following adoption of a national universal prestorage leukoreduction program for blood transfusions. Design, Setting, and Population: Retrospective before-and-after cohort study conducted from August 1998 to August 2000 in 23 academic and community hospitals throughout Canada, enrolling 14 786 patients who received red blood cell transfusions following cardiac surgery or repair of hip fracture, or who required intensive care following a surgical intervention or multiple trauma. Intervention: Universal prestorage leukoreduction program introduced by 2 Canadian blood agencies. A total of 6982 patients were enrolled during the control period and 7804 patients were enrolled following prestorage leukoreduction. Main Outcome Measures: All-cause in-hospital mortality and serious nosocomial infections (pneumonia, bacteremia, septic shock, all surgical site infections) occurring after first transfusion and at least 2 days after index procedure or intensive care unit admission. Secondary outcomes included rates of posttransfusion fever and antibiotic use. Results: Unadjusted in-hospital mortality rates were significantly lower following the introduction of leukoreduction compared with the control period (6.19% vs 7.03%, respectively; P = .04). Compared with the control period, the adjusted odds of death following leukoreduction were reduced (odds ratio [OR], 0.87; 95% confidence interval [CI], 0.75-0.99), but serious nosocomial infections did not decrease (adjusted OR, 0.97; 95% CI, 0.87-1.09). The frequency of posttransfusion fevers decreased significantly following leukoreduction (adjusted OR, 0.86; 95% CI, 0.79-0.94), as did antibiotic use (adjusted OR, 0.90; 95% CI, 0.82-0.99). Conclusion: A national universal leukoreduction program is potentially associated with decreased mortality as well as decreased fever episodes and antibiotic use after red blood cell transfusion in high-risk patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
CDC definitions for nosocomial infections, 1988
Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C., & Hughes, J. M. (1988) · American Journal of Infection Control · doi:10.1016/0196-6553(88)90053-3 · Cited by 5,672
Tissue Destruction by Neutrophils
Epstein, F. H., & Weiss, S. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902093200606 · Cited by 3,950
Horan, T. C., Gaynes, R. P., Martone, W. J., Jarvis, W. R., & Grace Emori, T. (1992) · American Journal of Infection Control · doi:10.1016/s0196-6553(05)80201-9 · Cited by 2,609
Horan, T. C., Gaynes, R. P., Martone, W. J., Jarvis, W. R., & Emori, T. G. (1992) · Infection Control and Hospital Epidemiology · doi:10.2307/30148464 · Cited by 1,167
JOHANSON, W. G., PIERCE, A. K., SANFORD, J. P., & THOMAS, G. D. (1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-77-5-701 · Cited by 1,087
Effect of blood transfusions on subsequent kidney transplants.
Opelz, G., SENGAR, D. P. S., Mickey, M. R., & Terasaki, P. I. (1973) · PubMed · Cited by 845
Brun-Buisson, C. (1995) · JAMA · doi:10.1001/jama.1995.03530120060042 · Cited by 772
Cited by
Corwin, H. L., Gettinger, A., Pearl, R. G., Fink, M. P., Levy, M. M., Abraham, E., MacIntyre, N. R., Shabot, M. M., Duh, M.-S., & Shapiro, M. J. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000104112.34142.79 · Cited by 1,348
Ferraris, V. A., Brown, J. R., Despotis, G. J., Hammon, J. W., Reece, T. B., Saha, S. P., Song, H. K., Clough, E. R., Shore-Lesserson, L. J., Goodnough, L. T., et al. (2011) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2010.11.078 · Cited by 1,289
Waselenko, J. K., MacVittie, T. J., Blakely, W. F., Pesik, N., Wiley, A. L., Dickerson, W. E., Tsu, H., Confer, D. L., Coleman, C. N., Seed, T., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-12-200406150-00015 · Cited by 766
Transfusion-related immunomodulation (TRIM): An update
Vamvakas, E. C., & Blajchman, M. A. (2007) · Blood Reviews · doi:10.1016/j.blre.2007.07.003 · Cited by 664
Self-citationVariation in critical care services across North America and Western Europe*
Wunsch, H., Angus, D. C., Harrison, D. A., Collange, O., Fowler, R., Hoste, E. A. J., de Keizer, N. F., Kersten, A., Linde-Zwirble, W. T., Sandiumenge, A., et al. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e318186aec8 · Cited by 624
Metadata
- Authors
- Hébert, P. C., Fergusson, D., Blajchman, M. A., Wells, G. A., Kmetic, A., Coyle, D., Heddle, N., Germain, M., Goldman, M., Toye, B., Schweitzer, I., vanWalraven, C., Devine, D., Sher, G. D., & for the Leukoreduction Study Investigators
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2003-04-16
- Volume
- 289
- Issue
- 15
- Pages
- 1941
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2109598404
- Cited by
- 389
- References
- 24
- FWCI
- 20.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical Outcomes Following Institution of the Canadian Universal Leukoreduction Program for Red Blood Cell Transfusions. https://app.cochat.ai/papers/10.1001/jama.289.15.1941
- The paper
- Hébert, P. C., Fergusson, D., Blajchman, M. A., Wells, G. A., Kmetic, A., Coyle, D., Heddle, N., Germain, M., Goldman, M., Toye, B., Schweitzer, I., vanWalraven, C., Devine, D., Sher, G. D., & for the Leukoreduction Study Investigators. (2003). Clinical Outcomes Following Institution of the Canadian Universal Leukoreduction Program for Red Blood Cell Transfusions. JAMA. https://doi.org/10.1001/jama.289.15.1941
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.